This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sevilla, N.
Right arrow Articles by Oldstone, M. B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sevilla, N.
Right arrow Articles by Oldstone, M. B. A.

 Previous Article  |  Next Article 

Journal of Virology, April 2000, p. 3284-3292, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Virus-Induced Diabetes in a Transgenic Model: Role of Cross-Reacting Viruses and Quantitation of Effector T Cells Needed To Cause Diseasedagger

Noemi Sevilla, Dirk Homann, Matthias von Herrath, Fernando Rodriguez, Stephanie Harkins, J. Lindsay Whitton, and Michael B. A. Oldstone*

Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037

Received 2 December 1999/Accepted 4 January 2000

Virus-specific cytotoxic T lymphocytes (CTL) at frequencies of >1/1,000 are sufficient to cause insulin-dependent diabetes mellitus (IDDM) in transgenic mice whose pancreatic beta  cells express as "self" antigen a protein from a virus later used to initiate infection. The inability to generate sufficient effector CTL for other cross-reacting viruses that fail to cause IDDM could be mapped to point mutations in the CTL epitope or its COO- flanking region. These data indicate that IDDM and likely other autoimmune diseases are caused by a quantifiable number of T cells, that neither standard epidemiologic markers nor molecular analysis with nucleic acid probes reliably distinguishes between viruses that do or do not cause diabetes, and that a single-amino-acid change flanking a CTL epitope can interfere with antigen presentation and development of autoimmune disease in vivo.


* Corresponding author. Mailing address: Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-8054. Fax: (858) 784-9981. E-mail: mbaobo{at}scripps.edu.

dagger This is publication no. 11201-NP from the Department of Neuropharmacology, The Scripps Research Institute, La Jolla, Calif.


Journal of Virology, April 2000, p. 3284-3292, Vol. 74, No. 7
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Horwitz, M. S., Efrat, S., Christen, U., von Herrath, M. G., Oldstone, M. B. A. (2009). Adenovirus E3 MHC inhibitory genes but not TNF/Fas apoptotic inhibitory genes expressed in {beta} cells prevent autoimmune diabetes. Proc. Natl. Acad. Sci. USA 106: 19450-19454 [Abstract] [Full Text]  
  • Filippi, C. M., von Herrath, M. G. (2008). Viral Trigger for Type 1 Diabetes: Pros and Cons. Diabetes 57: 2863-2871 [Full Text]  
  • Knoechel, B., Lohr, J., Zhu, S., Wong, L., Hu, D., Ausubel, L., Abbas, A. K. (2006). Functional and Molecular Comparison of Anergic and Regulatory T Lymphocytes.. J. Immunol. 176: 6473-6483 [Abstract] [Full Text]  
  • Fujinami, R. S., von Herrath, M. G., Christen, U., Whitton, J. L. (2006). Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease. Clin. Microbiol. Rev. 19: 80-94 [Abstract] [Full Text]  
  • Lewicki, H., Tishon, A., Homann, D., Mazarguil, H., Laval, F., Asensio, V. C., Campbell, I. L., DeArmond, S., Coon, B., Teng, C., Gairin, J. E., Oldstone, M. B. A. (2003). T Cells Infiltrate the Brain in Murine and Human Transmissible Spongiform Encephalopathies. J. Virol. 77: 3799-3808 [Abstract] [Full Text]  
  • Notkins, A. L. (2002). Immunologic and Genetic Factors in Type 1 Diabetes. J. Biol. Chem. 277: 43545-43548 [Full Text]  
  • Halbout, P., Briand, J.-P., Becourt, C., Muller, S., Boitard, C. (2002). T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse. J. Immunol. 169: 2436-2443 [Abstract] [Full Text]  
  • von Herrath, M. G., Wolfe, T., Mohrle, U., Coon, B., Hughes, A. (2001). Protection From Type 1 Diabetes in the Face of High Levels of Activated Autoaggressive Lymphocytes in a Viral Transgenic Mouse Model Crossed to the SV129 Strain. Diabetes 50: 2700-2708 [Abstract] [Full Text]  
  • Holz, A., Dyrberg, T., Hagopian, W., Homann, D., Herrath, M. v., Oldstone, M. B. A. (2000). Neither B Lymphocytes Nor Antibodies Directed Against Self Antigens of the Islets of Langerhans Are Required for Development of Virus-Induced Autoimmune Diabetes. J. Immunol. 165: 5945-5953 [Abstract] [Full Text]